Yong Ben - 06 Mar 2023 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Yong Ben
Issuer symbol
CRBP
Transactions as of
06 Mar 2023
Net transactions value
$0
Form type
4
Filing time
07 Mar 2023, 09:19:00 UTC
Next filing
22 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option(right to buy) Award $0 +5,307 $0.000000 5,307 06 Mar 2023 Common Stock 5,307 $2.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.